Cost-effectiveness of sacituzumab govitecan versus single-agent chemotherapy for metastatic triple-negative breast cancer: a trial-based analysis
Article in Cost Effectiveness and Resource Allocation (April 2024)
The most recent citing publications are shown below. View all 14 publications that cite this research output on Dimensions.
Analyses of quality of life in cancer drug trials - a review of measurements and analytical choices in post-reimbursement studies
Article in BMC Cancer (March 2024)
Mapping of Family Reported Outcome Measure (FROM-16) scores to EQ-5D: algorithm to calculate utility values
Article in Quality of Life Research (February 2024)